-transparent.png){kind=logo}
The variable clinical course and locally aggressive growth of giant cell tumours of bone cause problems in planning treatment. Curettage and bone grafting is the commonest form of surgical treatment, but recurrence rates as high as 40 per cent have been reported. Thirty-four patients with a GCT were treated in our clinic between years 1982 and 1990. There were three gr 1, 24 gr II and 7 grade III tumours. Operative treatment was carried out in 31. DNA flow cytometry was performed from the sample in 28 patients. The type of treatment played an important role in tumour prognosis: there were 10 recurrences after 18 intralesional procedures, but only one recurrence after tumour resection. DNA flow cytometry was not helpful in predicting tumour behaviour.
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
October 1989,
Cancer,
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
February 1996,
Chinese medical journal,
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
November 1990,
Cancer,
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
June 1994,
Zhonghua wai ke za zhi [Chinese journal of surgery],
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
January 1998,
Verhandlungen der Deutschen Gesellschaft fur Pathologie,
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
December 1991,
Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
October 1992,
Cancer,
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
January 2005,
Oncology reports,
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
June 1991,
Neurosurgery,
H Heliö, and
E Karaharju, and
T Böhling, and
S Nordling
January 1993,
The European respiratory journal,
